Purchase Agreement
This
Purchase Agreement (the
“Agreement”) is made effective as of December 18, 2009 by and between
DongYing (Jiangsu) Pharmaceutical Limited Company, the 100% owned subsidiary of
Sinobiopharma, Inc. (“DongYing”), located at Xx.
0 Xxxxxxxxx Xxxx, Xxxxxxx, Xxxxxxx, 000000, P. R. China and
Meisu Jining Secience and Technology (Nanjing) Limited Company (“ Meisu Jining”), located at
Xxxxxx Xincun, Jiangning Economic and
Technology Development District, Nanjing, Jiangsu, 210000, P. R. China,
to transfer the right of the Approval Certificate of Clinical Trial of
Eplerenone Capsules (the “Certificate”) owned by Meisu
Jining to DongYing.
In
reliance upon and in consideration of the following undertakings, the parties
agree as followings:
|
1.
|
Meisu
Jining owns the Approval Certificate of Clinical Trial of Eplerenone
Capsules issued by China National Food And Drug Administration, the
certificate number is 2007L01312, DongYing, within 5 days after this
Agreement being signed, issue 3,000,000 common shares to Meisu Jining to
buy this Certificate.
|
1
|
2.
|
Meisu
Jining should transfer all related technical documents and materials to
DongYing within 5 days after this Agreement being signed.
|
|
3.
|
After
this Agreement become effective, DongYing has the sole ownership to the
Certificate. Meisu Jining can not transfer this Certificate to any third
party.
|
|
4.
|
If
any dispute arises between the parties with respect to the matters covered
by this Agreement, the lawsuit will file to the jurisdiction at the
plaintiff’s location.
|
|
5.
|
This
Agreement becomes effective when both party sign or stamp. Both parties
have a copy of this Agreement and both copy has equal
effectiveness.
|
2
/s/
Meisu Jining Secience and Technology (Nanjing) Ltd.
Meisu
Jining Secience and Technology (Nanjing) Ltd.
Date:
12/18/09
/s/
DongYing (Jiangsu) Pharmaceutical Ltd.
DongYing
(Jiangsu) Pharmaceutical Ltd.
Date:
12/18/09
3
